drugset / Trial / NCT02546648
PeriOperative ISchemic Evaluation-3 Trial: A Pilot Study
Phase 3
Completed
100 enrolled
McMaster University
Hamilton Health Sciences Corporation · collabPopulation Health Research Institute · collab
RandomizedFactorialQuadruple-blindPrevention
Summary
A placebo-controlled, factorial trial to assess the impact of rosuvastatin and tranexamic acid (TXA) in patients undergoing noncardiac surgery who are at risk of a perioperative cardiovascular event.
Timeline
- Start
- 2015-02
- Primary completion
- 2015-10
- Completion
- 2016-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rosuvastatin | Small molecule | 20 mg | Oral |
| Subject | Tranexamic Acid | Small molecule | 1 g | Intravenous |